Why is Arvee Laborat. falling/rising?

As of 23-Sep, Arvee Laboratories (India) Ltd is experiencing a decline in its stock price, currently at 172.12, which reflects a decrease of 8.35 or 4.63%. Today's performance indicates that the stock has underperformed its sector by 4.07%. Despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock has seen a significant drop in investor participation, with delivery volume falling by 33.2% compared to the 5-day average. Additionally, the company has reported poor long-term growth, with operating profit increasing at a mere 1.80% annually over the last five years, and negative results in June 2025, including a 29.43% drop in net sales and a complete fall in profit before tax. The stock's high valuation, indicated by a price-to-book ratio of 6.2 and a return on equity of 4.4, further exacerbates concerns among investors. In the broader market context, Arvee Laboratories has shown a 1.85% increase over the past week, while the benchmark Sensex has decreased by 0.28%. However, the stock's year-to-date performance is down by 0.95%, contrasting with the Sensex's gain of 6.45%. This underperformance, coupled with the company's declining financial metrics and high valuation relative to peers, suggests that investors are cautious about the stock's future prospects. Overall, the combination of poor financial results, declining investor interest, and a high valuation compared to historical averages is contributing to the stock's current downward movement.